Andrew Sinclair
Investing Profile
About Andrew Sinclair
We are an international investment group that partners with entrepreneurs in the industry.
Abingworth thesis
About Team Strategy Portfolio Media Contact Investors Portfolio What drives our investments is the prospect of new treatments that will materially improve patients’ lives. That word “materially” is important: we are looking for game-changers and paradigm-shifts, not just incremental improvements. Browse our portfolio to see what this means in practice. For media enquires please email abingworth@medistrava.com or call +44 (0)20 3926 8535 © Abingworth LLP 2026 | Site by Ether Legal Privacy Policy Cookie Policy Terms & Conditions Contact info@abingworth.com +44 (0)20 7534 1500 1 St James's Market
Sector and stage focus
- Seed: Pharmaceuticals, BioTech
- Series A: Pharmaceuticals, BioTech
- general: London
Is Andrew Sinclair a fit for your round?
Upload your pitch deck and see whether Andrew Sinclair appears in your top 20 matches.
Find investors for your deck